JP2024539188A5 - - Google Patents
Info
- Publication number
- JP2024539188A5 JP2024539188A5 JP2024523770A JP2024523770A JP2024539188A5 JP 2024539188 A5 JP2024539188 A5 JP 2024539188A5 JP 2024523770 A JP2024523770 A JP 2024523770A JP 2024523770 A JP2024523770 A JP 2024523770A JP 2024539188 A5 JP2024539188 A5 JP 2024539188A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide sequence
- composition
- use according
- encoding
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163270929P | 2021-10-22 | 2021-10-22 | |
| US63/270,929 | 2021-10-22 | ||
| PCT/US2022/078551 WO2023070109A1 (en) | 2021-10-22 | 2022-10-21 | Compositions and methods for treating anal high-grade squamous intraepithelial lesion (hsil) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539188A JP2024539188A (ja) | 2024-10-28 |
| JP2024539188A5 true JP2024539188A5 (https=) | 2025-10-29 |
Family
ID=86059748
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523770A Pending JP2024539188A (ja) | 2021-10-22 | 2022-10-21 | 肛門高悪性度扁平上皮内病変（ｈｓｉｌ）を治療するための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230233659A1 (https=) |
| EP (1) | EP4419138A4 (https=) |
| JP (1) | JP2024539188A (https=) |
| KR (1) | KR20240099266A (https=) |
| CN (1) | CN118382457A (https=) |
| AU (1) | AU2022371672A1 (https=) |
| CA (1) | CA3235779A1 (https=) |
| CO (1) | CO2024006161A2 (https=) |
| MX (1) | MX2024004878A (https=) |
| WO (1) | WO2023070109A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS58080B1 (sr) * | 2014-11-04 | 2019-02-28 | Janssen Vaccines & Prevention Bv | Terapeutske vakcine protiv hpv16 |
| JP6470872B2 (ja) * | 2015-08-20 | 2019-02-13 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | 治療用ｈｐｖ１８ワクチン |
| WO2018209322A1 (en) * | 2017-05-11 | 2018-11-15 | Inovio Pharmaceuticals, Inc. | Clinical and immunologic biomarkers for regression of high grade cervical dysplasia and clearance of hpv16 and hpv18 infection after immunotherapy |
| WO2021202949A2 (en) * | 2020-04-02 | 2021-10-07 | Inovio Pharmaceuticals, Inc. | Compositions and methods for treating vulvar dysplasia |
-
2022
- 2022-10-21 JP JP2024523770A patent/JP2024539188A/ja active Pending
- 2022-10-21 KR KR1020247015465A patent/KR20240099266A/ko active Pending
- 2022-10-21 MX MX2024004878A patent/MX2024004878A/es unknown
- 2022-10-21 WO PCT/US2022/078551 patent/WO2023070109A1/en not_active Ceased
- 2022-10-21 EP EP22884739.8A patent/EP4419138A4/en active Pending
- 2022-10-21 CA CA3235779A patent/CA3235779A1/en active Pending
- 2022-10-21 CN CN202280082724.8A patent/CN118382457A/zh active Pending
- 2022-10-21 US US18/048,776 patent/US20230233659A1/en active Pending
- 2022-10-21 AU AU2022371672A patent/AU2022371672A1/en active Pending
-
2024
- 2024-05-15 CO CONC2024/0006161A patent/CO2024006161A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003218787B2 (en) | Virus-like particles of human papillomavirus | |
| CN116082521B (zh) | 痘病毒多抗原嵌合疫苗及其用途 | |
| US6458368B1 (en) | Attenuated microorganism strains expressing HPV proteins | |
| US5648459A (en) | Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions | |
| AU729336B2 (en) | Vaccine | |
| JP2023512519A5 (https=) | ||
| JP2019068852A5 (https=) | ||
| Han et al. | Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes | |
| Campo et al. | Papillomavirus prophylactic vaccines: established successes, new approaches | |
| AU6381794A (en) | Pharmaceuticals based on papillomaviruses | |
| JP2023527083A5 (https=) | ||
| CN118599010B (zh) | 一种hpv16/18/52治疗性疫苗、制备方法和应用 | |
| JP7777890B2 (ja) | Ｃｃｌ１１の用途 | |
| Zhao et al. | Codon usage roles in human papillomavirus | |
| JP2023522154A5 (https=) | ||
| CN101952320B (zh) | 具有免疫原性的物质 | |
| JP2024539188A5 (https=) | ||
| CN117305329A (zh) | 一种猴痘病毒核酸疫苗及其用途 | |
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| EP1427443A1 (en) | Vaccine using papilloma virus e proteins delivered by viral vector | |
| CN119736337A (zh) | Matv51重组腺病毒载体、应用、制备方法及hpv16/18/52治疗性疫苗 | |
| JP2022513438A5 (https=) | ||
| CN108424925A (zh) | 一种治疗性hpv核酸疫苗 | |
| JP2023526045A5 (https=) | ||
| WO2009090594A2 (en) | Alphavirus based vectors |